The HHS National Alzheimer's Plan Update for 2026-2035 guides federal dementia work through 2035 and centers coverage, cost, and access for spouses and partners. It does not create new drug coverage itself, but it pushes high-value care and stronger family supports alongside current Medicare rules. The National Plan to Address Alzheimer's Disease and Related Dementias is the federal roadmap for risk reduction, research, care, and family support. For spouses and partners, the useful questions are who qualifies for treatment, what you pay, and where daily help comes from.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What changed in the 2026 Update?
- Will Medicare cover Leqembi or Kisunla for your spouse?
- What will treatment and care cost your household?
- Where can spouses get day-to-day help?
- What should partners check this month?
What changed in the 2026 Update?
Congress extended the national effort when it enacted the NAPA Reauthorization Act on Oct. 1, 2024. The law runs the National Alzheimer's Project through 2035. It directed HHS to deliver a full plan update in 2026. The National Institute on Aging describes that mandate in its NAPA summary. Becker's Hospital Review reports that HHS announced the 2026 Update on Oct.
22, 2026. The update replaces six longstanding goals with four. The four cover risk reduction, discovery and innovation, high-value care, and family supports. See the four-goal summary. The Assistant Secretary for Planning and Evaluation hosts the official plan series. It lists the 2026 Update with prior yearly updates. That listing confirms the plan as the roadmap guiding agency actions through 2035.
Will Medicare cover Leqembi or Kisunla for your spouse?
CMS states that Medicare covers Leqembi after FDA traditional approval on July 6, 2023 and Kisunla after FDA traditional approval on July 2, 2024. Coverage applies only to mild cognitive impairment or mild dementia with confirmed amyloid pathology. The prescribing clinician must report to a registry.
See the broader Medicare coverage statement. Check these three points with the clinic: Ask the memory clinic to confirm each point before you plan travel or time off. If one point is missing, coverage does not apply. Keep the amyloid result and registry note with your records.
- mild cognitive impairment or mild dementia diagnosis
- confirmed amyloid pathology
- clinician registry reporting
What will treatment and care cost your household?
Being Patient lists Leqembi at about $26,500 per year and Kisunla at about $32,000 per year. The same comparison puts an 18-month Kisunla course at about $48,700. See the Leqembi versus Kisunla cost comparison. Being Patient also notes added PET, MRI-monitoring, and infusion costs. Traditional Medicare's 20 percent Part B coinsurance can top $5,000 yearly without Medigap.
Ask for the full yearly estimate in writing. The Alzheimer's Association estimates dementia care will cost the U.S. $409 billion in 2026 and nearly $1 trillion by 2050. It puts lifetime cost at $405,262 per person in 2024 dollars. It finds families carry 70 percent through unpaid care and out-of-pocket spending. See the national Facts and Figures report.
Where can spouses get day-to-day help?
Unpaid caregivers gave over 19 billion hours in 2025, valued above $446 billion. Spouses and partners provide most daily supervision. That strain raises risks of emotional distress and health harm. The Alzheimer's Association reports these totals in Facts and Figures. CMS launched the 8-year GUIDE Model on July 1, 2024 with 390 organizations.
It pays for dementia care coordination plus caregiver education, support groups, and defined respite. It serves community-dwelling Original Medicare beneficiaries with an unpaid primary caregiver. CMS describes the model as a path to more complete dementia care. Ask your primary care office if it joins a GUIDE organization. Ask what respite hours and training are covered. Use those hours for sleep, health visits, and backup planning.
What should partners check this month?
Confirm drug eligibility, Medigap status, and local GUIDE access in one round of calls. Bring medication lists, amyloid results, and a daily-care log. Ask for costs in writing, including scans and monitoring.
If treatment is not an option, shift focus to care coordination and respite. Schedule supervision breaks before exhaustion hits. Keep one contact for care questions and one for coverage questions.
You Might Also Like
- The $100 Million PROTECT-Cog Alzheimer’s Study Announced in 2026: Questions Adult Children Can Ask About the Research
- The NIA 2026 Dementia Care and Caregiving Summit Report: What the Report Establishes and Leaves Unanswered for Spouses and Partners
- The Ideal Dementia Care Map Discussed by NIA in 2026: What the Report Establishes and Leaves Unanswered for Spouses and Partners
